FLOW CYTOMETRIC ANALYSIS FOR T CELL PROLIFERATION
FLOW CYTOMETRIC ANALYSIS FOR T CELL PROLIFERATION
批准号:
6563976
负责人:
SMITA GHANEKAR
金额:
$29.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-02-19 至 2002-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Description: (provided by applicant)
T cell proliferation and the calculation of a stimulation index are one of the
mostly widely used methods in both mouse and man to demonstrate antigen
specific immunity. We propose to define a "second generation" assay to
replace traditional lymphocyte proliferation assays using [3H]thymidine
uptake. Multiparameter flow cytometry will be used to assess antigen-specific
T cell proliferation by measuring incorporation of BrdU, a thymidine analog.
In addition to proliferating T cells, surface markers associated with
proliferating cells will be examined. Surface markers to be examined will
include CO27, CD45RO/RA, and CO95. These are all markers that can be used,
singly or in combination, to distinguish naive from memory cells. Antigen-specific
BrdU incorporation will be used to identify proliferating antigen-responsive
cells, so that analysis of other markers can be perfoffi1ed by
gating on these cells. In a preliminary study using SEB as a stimulus,
positive correlation was observed between flow cytometric measurement of
proliferating CD4+ T cells by BrdU incorporation and a standard proliferation
assay measuring [3H]thymidine uptake by PBMC. We propose to extend the use of
BrdU proliferation assay using flow cytometry in assessing T cell
proliferative responses to CMV, flu, and tumor antigens.
The aim of this pilot project will be to correlate lymphocyte proliferation
assay using non-radioactive BrdU incorporation measured by multiparametric
flow cytometry and a standard radioactive [3H]thymidine incorporation assay in
the following systems: CMV, influenza, and at least one of the candidate
cancer antigens to be evaluated by the consortium (MAGE-3, HER2, CEA, or
gp100).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文